EMA expects to review data on Bayer's Diane-35; U.K. study adds to data on GSK shot's narcolepsy links;

@FiercePharma: EMA sounds a bit perturbed about France's suspension of Diane-35. But it will review data when France asks. More | Follow @FiercePharma

 @AlisonBFierce: Life Technologies established an international flu network to develop a speedy monitoring system and better vaccine. News | Follow @AlisonBFierce

@EricPFierce: BASF says it has finally gotten the Pronova deal closed making it one of the largest fish oil producers in the world. Release | Follow @EricPFierce

> The European Medicines Agency expects France to request a safety review of Bayer's acne drug Diane-35, which French authorities suspended yesterday. Report

> A U.K. study joined research from Sweden and Finland in drawing links between GlaxoSmithKline's ($GSK) Pandemrix vaccine and cases of the rare sleep disorder narcolepsy. Report

> Japan's Daiichi Sankyo, which owns a majority stake in India's Ranbaxy Laboratories, reported 9-month profits that almost tripled year-over-year because of legal charges in the previous period. Report

> A Pennsylvania woman sued Bayer, claiming the German company failed to warn of serious risks with its intrauterine contraceptive Mirena. Report

> Fitch Ratings raised Roche ($RHHBY) to a "AA," citing its market-leading position in the fast-growing oncology segment and limited exposure to patent expirations. Report

Biotech News

 @FierceBiotech: Celsion shares routed after PhIII liver cancer study flops. News | Follow @FierceBiotech

@JohnCFierce: AstraZeneca's Soriot is going to have to do something bold, something dramatic, and something a little loony. In that order. | Follow @JohnCFierce

@RyanMFierce: Holland's health minister is sounding very German on drug pricing, wants to chop cost of Genzyme and Shire therapies. More | Follow @RyanMFierce

> Venture firm preps $100M fund for late-stage life sciences investments. News

> Vanda slides after drug fails PhII/III for depression. Item

> Is AstraZeneca getting ready to buy a pipeline? Report

> Pharmaxis suffers FDA committee upset, nabs up to $40M in financing. Article

> Genentech flashes PhIII progress for prized Rituxan successor. Story

Medical Device News

 @FierceMedDev: Startup brings molecular diagnostics to India's swelling market. Article | Follow @FierceMedDev

 @MarkHFierce: Today's Dx Extra: Another company will take on development of an RA Dx. Story | Follow @MarkHFierce

 @DamianFierce: After a weak Q4, Zimmer's counting on restructuring to save 2013 profits. News | Follow @DamianFierce

> Cardiovascular Systems PAD treatment tech kickstarts revenue growth. Story

> Tyrx's dissolvable antibacterial envelope wins Canadian approval. Report

Vaccines News

> MIT explores DNA vaccine delivery. Item

> Life establishes international flu network. More

> CDC: Adult vaccination rates 'unacceptably low.' Report

> FDA expands use of Pfizer's Prevnar 13. Article

> GSK, Biological E partner on childhood vaccine. Story

Pharma Manufacturing News

> Cargo theft up dramatically in Mexico. Item

> Sanofi's Genzyme looking hard at continuous manufacturing. News

> Biogen, Merck, Novartis, others have plants recognized for innovations. More

> Teva, P&G start on OTC plant in India. Story

And Finally... Here's how morale goes into a downward spiral: Rude behavior at work is increasing--and it prompts co-workers to dial back their efforts, a study found. Report